Dr. Mohan Purushothaman is an entrepreneur with a strong track record in the life sciences industry spanning both therapeutics and diagnostics. He has several years of experience in the Pharma industry followed by more than a decade of work as a strategic advisor to various pharmaceutical companies worldwide. After spending 5 years at Roche where he spearheaded the formulation of life-cycle pricing strategies for a large number of their products, he built a successful practice at Net Margins which eventually was acquired by Alliance Life Sciences. At Alliance, he was the Global Practice Lead for Pricing and Market Access until 2014. In these challenging assignments, he guided the development of strategies for a number of products across multiple therapeutic areas and markets. He holds a Ph.D. from the Johns Hopkins University with a focus on Pharmaceutical Pricing, prior to which he was a Research Fellow at Harvard University.
Dr. Eldon Jupe graduated magna cum laude from Texas A&M University with a BS in Biochemistry and an MS in Genetics. He holds a Ph.D. in Biochemistry from Louisiana State University and completed Postdoctoral studies at the University of Cincinnati. He brings over 30 years of experience in biochemistry, toxicology and human genetics. He co-founded InterGenetics Inc., served as its VP, CSO and COO and raised more than $30M in financing and grants over time. He led a team that developed OncoVue®—a proprietary test for breast cancer.
